France· FR:62307903
CEBEMYXINE, collyre en solution
A medicinal product containing sulfate de polymyxine b + sulfate de néomycine, registered in France by LABORATOIRE CHAUVIN, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- SULFATE DE POLYMYXINE B + SULFATE DE NÉOMYCINE
- Manufacturer
- LABORATOIRE CHAUVIN
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009301930821 flacon(s) compte-gouttes polyéthylène basse densité (PEBD) de 10 ml avec système de sécuritéEUR 2.09
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sulfate de polymyxine b + sulfate de néomycine in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/82c5b27c-75a6-4e86-893d-17ddbe44b853 GET /v1/drugs/82c5b27c-75a6-4e86-893d-17ddbe44b853?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62307903",
"date_amm": "1997-04-11",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "SULFATE DE POLYMYXINE B + SULFATE DE NÉOMYCINE",
"statut_amm": "Autorisation abrogée",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "collyre en solution",
"voies_administration": "ophtalmique",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about sulfate de polymyxine b + sulfate de néomycine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.